View More Recent Stories

Feb 6, 2025 04:00PM EPIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that ESSA Pharma Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Feb 4, 2025 11:04AM ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIX
Feb 1, 2025 01:11PM ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIX
Jan 29, 2025 04:00PM EPIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that ESSA Pharma Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Nov 4, 2024 03:55AM Piper Sandler Downgrades ESSA Pharma (EPIX) to Neutral
Nov 4, 2024 12:33AM Oppenheimer Downgrades ESSA Pharma (EPIX) to Perform
Nov 1, 2024 03:05PM ESSA Pharma Inc. (EPIX) call put ratio 4.8 calls to 1 put with focus on March 2.5 and 5 puts as share price down 70%
Nov 1, 2024 07:45AM Jones Trading Downgrades ESSA Pharma (EPIX) to Hold
Sep 16, 2024 07:56AM Oppenheimer Reiterates Outperform Rating on ESSA Pharma (EPIX)
Sep 16, 2024 07:48AM Piper Sandler Reiterates Overweight Rating on ESSA Pharma (EPIX)
Sep 9, 2024 07:53AM Piper Sandler Reiterates Overweight Rating on ESSA Pharma (EPIX)
Aug 29, 2024 07:52AM Piper Sandler Reiterates Overweight Rating on ESSA Pharma (EPIX)
Aug 5, 2024 08:16AM ESSA Pharma Inc. (EPIX) Tops Q3 EPS by 9c
View More Recent Stories